Given that gains of the chromosome region 6p22.3 is observed in 16% of MM patients [4], we hypothesized initially that the DEK gene would be amplified and overexpressed in MM patients who carry 6p22.3 amplification, as observed in the other solid tumors [12, 13]. The gene discussed is DEK; the disease is Miyoshi myopathy.